MX2023000904A - Un peptido utilizado para agentes inmunoterapeuticos. - Google Patents

Un peptido utilizado para agentes inmunoterapeuticos.

Info

Publication number
MX2023000904A
MX2023000904A MX2023000904A MX2023000904A MX2023000904A MX 2023000904 A MX2023000904 A MX 2023000904A MX 2023000904 A MX2023000904 A MX 2023000904A MX 2023000904 A MX2023000904 A MX 2023000904A MX 2023000904 A MX2023000904 A MX 2023000904A
Authority
MX
Mexico
Prior art keywords
peptide
peptide unit
immunotherapeutic agent
unit
present specification
Prior art date
Application number
MX2023000904A
Other languages
English (en)
Inventor
Hyo Joon Kim
Original Assignee
3H Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3H Bio Co Ltd filed Critical 3H Bio Co Ltd
Publication of MX2023000904A publication Critical patent/MX2023000904A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

Siempre que un péptido proporcionado en la presente incluya al menos una unidad peptídica, y la unidad peptídica puede incluir al menos un epítopo de células B, al menos un epítopo Th y un número apropiado de partes auxiliares. La unidad peptídica es una porción diseñada para inducir uniformemente sólo el anticuerpo deseado mientras exhibe un cierto nivel de inmunogenicidad en el cuerpo de un sujeto. Además, la unidad de péptido está diseñada con una longitud relativamente corta y, por lo tanto, tiene las características de una síntesis fácil y un bajo costo de producción. El péptido tiene propiedades adecuadas para su uso como inmunoterapéutico debido a las características de la unidad peptídica descrita anteriormente. En la presente memoria descriptiva, los principios de diseño del péptido y la unidad peptídica se describen en detalle.
MX2023000904A 2020-07-22 2021-07-21 Un peptido utilizado para agentes inmunoterapeuticos. MX2023000904A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20200091033 2020-07-22
KR20200091032 2020-07-22
KR1020200091031 2020-07-22
PCT/KR2021/009453 WO2022019665A1 (ko) 2020-07-22 2021-07-21 면역 치료제용 펩타이드

Publications (1)

Publication Number Publication Date
MX2023000904A true MX2023000904A (es) 2023-02-22

Family

ID=79729919

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000904A MX2023000904A (es) 2020-07-22 2021-07-21 Un peptido utilizado para agentes inmunoterapeuticos.

Country Status (9)

Country Link
US (2) US20230134067A1 (es)
EP (2) EP4186916A1 (es)
JP (1) JP2023534350A (es)
KR (1) KR20230042053A (es)
AU (1) AU2021311894A1 (es)
BR (1) BR112023000620A2 (es)
CA (1) CA3189004A1 (es)
MX (1) MX2023000904A (es)
WO (1) WO2022019665A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3189004A1 (en) 2020-07-22 2022-01-27 3H Bio. Co., Ltd. A peptide used for immunotherapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413935B1 (en) 1993-09-14 2002-07-02 Epimmune Inc. Induction of immune response against desired determinants
AU1582797A (en) * 1996-01-24 1997-08-20 Epimmune, Inc. Induction of immune response against desired determinants
DE60143300D1 (de) * 2000-09-04 2010-12-02 Kim Hyo Joon Mimetische peptiden für epitop von apolipoprotein b-100, concatemer und modifizierte peptide davon, und die impfstoffzusammensetzung mit solchen peptiden
KR100639397B1 (ko) * 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
AU2007300842B2 (en) * 2006-09-25 2011-01-27 Sj Biomed Inc. Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
CN103961702B (zh) * 2013-02-05 2019-04-09 日东电工株式会社 粘膜给予用wt1肽癌症疫苗组合物
SG10201808312YA (en) * 2014-03-25 2018-10-30 The Government Of The Us Secretary Of The Army Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines
CN107072963B (zh) 2014-09-03 2020-07-07 吉倪塞思公司 治疗性纳米粒子和相关的组合物、方法和系统
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
CA3189004A1 (en) 2020-07-22 2022-01-27 3H Bio. Co., Ltd. A peptide used for immunotherapeutics

Also Published As

Publication number Publication date
US11952414B2 (en) 2024-04-09
EP4368638A2 (en) 2024-05-15
CA3189004A1 (en) 2022-01-27
WO2022019665A1 (ko) 2022-01-27
US20230134067A1 (en) 2023-05-04
KR20230042053A (ko) 2023-03-27
JP2023534350A (ja) 2023-08-09
BR112023000620A2 (pt) 2023-03-28
US20230087676A1 (en) 2023-03-23
AU2021311894A1 (en) 2023-02-02
EP4186916A1 (en) 2023-05-31

Similar Documents

Publication Publication Date Title
EP2542571A4 (en) OLIGOMER SPECIFIC BETA AMYLOID EPITOPE AND ANTIBODIES
MX335965B (es) Anticuerpos especificos para la forma de protofibrillas de la proteina beta-amiloide.
MX2023000904A (es) Un peptido utilizado para agentes inmunoterapeuticos.
TW200801035A (en) Peptide vaccine for producing anti-amyloid beta peptide antibody
MX341369B (es) Anticuerpo anti-beta-amiloide humanizado seguro y funcional.
WO2019112347A3 (ko) 악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항원 수용체 및 이의 용도
SG11201806502UA (en) Conjugate of therapeutic enzymes
PL2054431T3 (pl) Konformery adhezyn bakteryjnych
NZ595863A (en) Antibodies to egfl7 and methods for their use
MX360785B (es) Derivados de amina de compuestos de 1-oxa-4,9-diazaespiro undecano que tienen actividad multimodal contra el dolor.
PH12020551037A1 (en) Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
MX2020007565A (es) Nuevos oxadiazoles.
WO2010107874A3 (en) Methods for affecting body composition using amylin agonists
WO2019212356A8 (en) Tetrazines for high click conjugation yield in vivo and high click release yield
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
WO2020069050A3 (en) Methods of treating neurodegenerative diseases
RU2010108521A (ru) Способ получения затвердевающего в воде порошка
WO2021132482A3 (ja) 発電用磁歪素子および磁歪発電デバイス
WO2021067611A3 (en) Compositions and methods for treating alzheimer's disease
EP2833221A3 (en) Silicon overcoil balance spring
CN201967867U (zh) 多功能手表
NZ602906A (en) Novel interferon-alpha-producing bone marrow dendritic cells
CN207666766U (zh) 眼罩与耳罩组合体
WO2007039919A8 (en) Crystalline forms of anastrozole
AR112975A2 (es) Anticuerpo humanizado